Krunal Desai

Krunal Desai is a seasoned professional with extensive experience in biotechnology and drug development, currently serving as Senior Associate Director in Strategy & Operations at Boehringer Ingelheim since January 2012. Desai's previous roles include leading medical education and scientific affairs, and conducting research in non-clinical drug safety focused on reagent generation and toxicological evaluations. Prior experience includes work as a molecular technologist at Caris Life Sciences, where Desai contributed to cancer detection assay development, and as a research associate at Texas A&M Health Science Centre, studying gene effects in spinal muscular atrophy. Academic achievements include an MBA from NYU Stern School of Business and two degrees in Biotechnology from Texas A&M University and Padmashree Dr. D.Y. Patil University.